SCHEMBL753032

SCHEMBL753032

C[C@H](c1cc(Oc2ncc(C(=O)O)cn2)ccc1Cl)[C@@](O)(c1ccnc(Cl)c1)C(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
PTGER4 P35408 2/20 0.33
PPARG P37231 1/20 0.33
HRH3 Q9Y5N1 2/20 0.33
EGLN1 Q9GZT9 1/20 0.32
P2RX3 P56373 1/20 0.32
RAF1 P04049 2/20 0.32
KDR P35968 3/20 0.31
FLT1 P17948 2/20 0.31
ABL1 P00519 2/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
PLK4 O00444 1/20 0.31
CIT O14578 1/20 0.31
AURKA O14965 1/20 0.31
MUSK O15146 1/20 0.31
EPHB6 O15197 1/20 0.31
MAPK13 O15264 1/20 0.31
MLNR O43193 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL479959 1.00 THRA (0.35) THRATHRBPTGER4PPARGHRH3
SCHEMBL480027 0.93 PTGER4 (0.35) THRATHRBPTGER4PPARGHRH3
SCHEMBL754885 0.91 KDR (0.36) HRH3P2RX3RAF1KDRABL1
SCHEMBL480025 0.91 KDR (0.36) HRH3P2RX3RAF1KDRABL1
SCHEMBL15789808 0.90 RAF1 (0.31) RAF1KDRMEN1KMT2ANTRK1
SCHEMBL755576 0.89 HRH3 (0.42) THRATHRBHRH3P2RX3ADRB1
SCHEMBL733429 0.89 HRH3 (0.42) THRATHRBHRH3P2RX3ADRB1
SCHEMBL15789721 0.88 ROCK2 (0.33) RAF1KDRFLT1ABL1MEN1
SCHEMBL479981 0.84 KMO (0.36) HRH3P2RX3RAF1KMO
SCHEMBL754445 0.84 KMO (0.36) HRH3P2RX3RAF1KMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
WO-2010108902-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 THRA 57/4885THRB 132/4885PTGER4 543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.